Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret ...

Shares of Indian pharmaceutical companies slid 2% on Wednesday after U.S. President Donald Trump said he intends to impose ...

U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Septerna stood out from the crowd of biotech IPOs last year due to the lack of clinical data to hand. Now, the data are ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Stock futures pointed lower Wednesday morning as investors watched for fresh insights from the Federal Reserve and evaluated ...

Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per ...